Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial

STUDY QUESTION: Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY ANSWER: Oral dydrogesterone demonstrated non-inferiority to MVP gel for the presence of fetal heartbeats at 12 weeks of gestation (non-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hum Reprod
Egile Nagusiak: Griesinger, Georg, Blockeel, Christophe, Sukhikh, Gennady T, Patki, Ameet, Dhorepatil, Bharati, Yang, Dong-Zi, Chen, Zi-Jiang, Kahler, Elke, Pexman-Fieth, Claire, Tournaye, Herman
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6238366/
https://ncbi.nlm.nih.gov/pubmed/30304457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/humrep/dey306
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak